Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.72B | 2.82B | 2.97B | 2.78B | 2.12B | Gross Profit |
1.22B | 1.26B | 1.28B | 1.23B | 787.05M | EBIT |
149.86M | 201.31M | 214.33M | 205.81M | -102.44M | EBITDA |
205.54M | 253.94M | 276.31M | 257.08M | -432.19M | Net Income Common Stockholders |
107.25M | 163.87M | 181.74M | 137.02M | -438.99M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
29.64M | 21.36M | 33.70M | 30.11M | 88.30M | Total Assets |
1.89B | 1.80B | 1.84B | 1.84B | 1.87B | Total Debt |
826.55M | 747.86M | 887.63M | 871.40M | 1.12B | Net Debt |
796.91M | 726.50M | 853.92M | 841.29M | 1.03B | Total Liabilities |
1.29B | 1.24B | 1.41B | 1.52B | 1.66B | Stockholders Equity |
599.02M | 560.63M | 420.68M | 318.57M | 200.25M |
Cash Flow | Free Cash Flow | |||
55.41M | 150.53M | 61.84M | 144.30M | 104.29M | Operating Cash Flow |
104.56M | 200.15M | 125.88M | 168.44M | 126.35M | Investing Cash Flow |
-51.69M | -49.62M | -64.04M | -24.14M | -22.06M | Financing Cash Flow |
-44.51M | -162.99M | -58.15M | -202.38M | -61.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.76B | 10.45 | 19.51% | 3.46% | 10.17% | -4.71% | |
73 Outperform | $303.17M | 10.43 | 11.76% | 3.32% | -5.46% | -1.09% | |
73 Outperform | $5.69B | 6.26 | 53.70% | ― | 2.09% | 26.18% | |
70 Outperform | $169.97M | 12.40 | 5.97% | 2.72% | -2.01% | 2.08% | |
68 Neutral | $1.35B | 18.73 | 25.29% | 2.41% | -13.05% | ― | |
64 Neutral | $449.34M | 5.50 | 13.67% | 2.12% | -4.84% | -49.08% | |
62 Neutral | $6.90B | 11.24 | 2.93% | 3.89% | 2.68% | -24.71% |
On May 22, 2025, Caleres‘ Board of Directors amended the company’s Bylaws to reduce the number of directors from twelve to eleven. During the Annual Meeting of Shareholders on the same day, eleven directors were elected for a one-year term, Ernst & Young LLP was ratified as the independent registered public accountants, and an advisory resolution on executive compensation was approved.
The most recent analyst rating on (CAL) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on Caleres stock, see the CAL Stock Forecast page.